The ROE (Return on Equity) of ReShape Lifesciences Inc (RSLS) is 2818.18%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | 2818.18% |
| 2023-12-31 | -170.90% |
| 2022-12-31 | -1262.57% |
| 2021-12-31 | -142.45% |
| 2020-12-31 | -264.03% |
| 2019-12-31 | -149.40% |
| 2018-12-31 | -285.13% |
| 2017-12-31 | -99.03% |
| 2016-12-31 | -31.83% |
| 2015-12-31 | 3536.36% |